By Dr Sunil Badve

Journal articles

Bose B; Chung EYM; Hong R; Strippoli GFM; Johnson DW; Yang WL; Badve SV; Palmer SC, 2022, 'Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis', Journal of Nephrology, 35, pp. 1159 - 1170, http://dx.doi.org/10.1007/s40620-022-01268-2

Lioufas NM; Pascoe EM; Hawley CM; Elder GJ; Badve SV; Block GA; Johnson DW; Toussaint ND, 2022, 'Systematic Review and Meta-Analyses of the Effects of Phosphate-Lowering Agents in Nondialysis CKD', Journal of the American Society of Nephrology, 33, pp. 59 - 76, http://dx.doi.org/10.1681/ASN.2021040554

Bose B; Badve SV; Johnson DW; Hawley C; Jha V; Reidlinger D; Peh CA, 2022, 'Treatment preferences for primary membranous nephropathy: Results of a multinational survey among nephrologists in the South Asia Pacific region', Nephrology, 27, pp. 35 - 43, http://dx.doi.org/10.1111/nep.13953

Ha J; Freedman B; Kelly DM; Neuen BL; Perkovic V; Jun M; Badve S, 2022, 'Lower Glomerular Filtration Rate and Higher Albuminuria Are Associated With Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 33, pp. 297 - 298, http://dx.doi.org/10.1681/asn.20223311s1297c

Rangan GK; Wong ATY; Munt A; Zhang JQJ; Saravanabavan S; Louw S; Allman-Farinelli M; Badve SV; Boudville N; Chan J; Coolican H; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Gregory AV; Haloob I; Hawley CM; Holt J; Howard K; Howell M; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Pascoe E; Peduto A; Rangan A; Roger SD; Sherfan J; Sud K; Torres VE; Vilayur E; Harris DCH, 2022, 'Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease.', NEJM Evid, 1, pp. EVIDoa2100021, http://dx.doi.org/10.1056/EVIDoa2100021

Hultin S; Johnson DW; Badve SV, 2021, 'Recent evidence on the effect of treatment of metabolic acid on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, 30, pp. 467 - 473, http://dx.doi.org/10.1097/MNH.0000000000000728

Badve SV, 2021, 'Editor's note', Internal Medicine Journal, 51, pp. 1368, http://dx.doi.org/10.1111/imj.15462

Jun M; Harris K; Heerspink HJL; Badve SV; Jardine MJ; Harrap S; Hamet P; Marre M; Poulter N; Kotwal S; Gallagher M; Perkovic V; Chalmers J; Woodward M, 2021, 'Variability in estimated glomerular filtration rate and the risk of major clinical outcomes in diabetes: Post hoc analysis from the ADVANCE trial', Diabetes, Obesity and Metabolism, 23, pp. 1420 - 1425, http://dx.doi.org/10.1111/dom.14351

Tiku A; Johnson DW; Badve SV, 2021, 'Recent evidence on the effect of urate-lowering treatment on the progression of kidney disease', Current Opinion in Nephrology and Hypertension, 30, pp. 346 - 352, http://dx.doi.org/10.1097/MNH.0000000000000699

Hultin S; Hood C; Campbell KL; Toussaint ND; Johnson DW; Badve SV, 2021, 'A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes', Kidney International Reports, 6, pp. 695 - 705, http://dx.doi.org/10.1016/j.ekir.2020.12.019

Conley M; Lioufas N; Toussaint ND; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Pedagogos E; Valks A; Campbell KL, 2021, 'Dietary Phosphate Consumption in Australians With Stages 3b and 4 Chronic Kidney Disease', Journal of Renal Nutrition, 31, pp. 155 - 163, http://dx.doi.org/10.1053/j.jrn.2020.02.007

O'Hara DV; Parkhill TR; Badve SV; Jun M; Jardine MJ; Perkovic V, 2021, 'The effects of dipeptidyl peptidase-4 inhibitors on kidney outcomes', Diabetes, Obesity and Metabolism, 23, pp. 763 - 773, http://dx.doi.org/10.1111/dom.14281

Davies SJ; Zhao J; Morgenstern H; Zee J; Bieber B; Fuller DS; Sloand JA; Vychytil A; Kawanishi H; Johnson DW; Wang AYM; Kanjananbuch T; Boongird S; Moraes TP; Badve SV; Pisoni RL; Perl J, 2021, 'Low Serum Potassium Levels and Clinical Outcomes in Peritoneal Dialysis—International Results from PDOPPS', Kidney International Reports, 6, pp. 313 - 324, http://dx.doi.org/10.1016/j.ekir.2020.11.021

Palmer SC; Tendal B; Mustafa RA; Vandvik PO; Li S; Hao Q; Tunnicliffe D; Ruospo M; Natale P; Saglimbene V; Nicolucci A; Johnson DW; Tonelli M; Rossi MC; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque LI; Lloyd A; Ahmad N; Liu Y; Tiv S; Millard T; Gagliardi L; Kolanu N; Barmanray RD; McMorrow R; Raygoza Cortez AK; White H; Chen X; Zhou X; Liu J; Rodríguez AF; González-Colmenero AD; Wang Y; Li L; Sutanto S; Solis RC; Díaz González-Colmenero F; Rodriguez-Gutierrez R; Walsh M; Guyatt G; Strippoli GFM, 2021, 'Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: Systematic review and network meta-analysis of randomised controlled trials', The BMJ, 372, http://dx.doi.org/10.1136/bmj.m4573

CHENG L; Badve S; on behalf of the CKD-FIX Study Investigators, L , 2021, 'POS-311 POLYPHARMACY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HIGH PROGRESSION RISK', Kidney International Reports, 6, pp. S134 - S134, http://dx.doi.org/10.1016/j.ekir.2021.03.327

Toussaint ND; Pedagogos E; Lioufas NM; Elder GJ; Pascoe EM; Badve SV; Valks A; Block GA; Boudville N; Cameron JD; Campbell KL; Chen SSM; Faull RJ; Holt SG; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Hooi LS; Narayan O; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Hawley CM; Wyndham R; Vilayur E; Cooper B; Wong MG; Tan KS; van Eps C; Cho Y; Barbara J; Paizis K; McMahon LP; Nelson C; Gafor AHA; Meng OL; Mushahar L; Maher E, 2020, 'A randomized trial on the effect of phosphate reduction on vascular end points in CKD (improve-CKD)', Journal of the American Society of Nephrology, 31, pp. 2653 - 2666, http://dx.doi.org/10.1681/ASN.2020040411

Wong ATY; Munt A; Allman-Farinelli M; Badve SV; Boudville N; Coolican H; Chandra AN; Coulshed S; Fernando M; Grantham J; Haloob I; Harris DCH; Hawley CM; Holt J; Johnson DW; Kumar K; Lee VW; Lonergan M; Mai J; Rangan A; Roger SD; Saravanabavan S; Sud K; Torres VE; Vilayur E; Zhang JQJ; Rangan GK, 2020, 'Assessment of dietary sodium intake using the scored salt questionnaire in autosomal dominant polycystic kidney disease', Nutrients, 12, pp. 1 - 14, http://dx.doi.org/10.3390/nu12113376

Chen Q; Wang Z; Zhou J; Chen Z; Li Y; Li S; Zhao H; Badve SV; Lv J, 2020, 'Effect of urate-lowering therapy on cardiovascular and kidney outcomes: A systematic review and meta-analysis', Clinical Journal of the American Society of Nephrology, 15, pp. 1576 - 1586, http://dx.doi.org/10.2215/CJN.05190420

Badve SV; Pascoe EM, 2020, 'Allopurinol and Chronic Kidney Disease. Reply', The New England journal of medicine, 383, pp. 1691 - 1692, http://dx.doi.org/10.1056/NEJMc2026125

Ashley J; McArthur E; Bota S; Harel Z; Battistella M; Molnar AO; Jun M; Badve SV; Garg AX; Manuel D; Tanuseputro P; Wells P; Mavrakanas T; Rhodes E; Sood MM, 2020, 'Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants', American Journal of Kidney Diseases, 76, pp. 311 - 320, http://dx.doi.org/10.1053/j.ajkd.2020.02.446

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Neal B, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Lioufas NM; Pedagogos E; Hawley CM; Pascoe EM; Elder GJ; Badve SV; Valks A; Toussaint ND, 2020, 'Aortic Calcification and Arterial Stiffness Burden in a Chronic Kidney Disease Cohort with High Cardiovascular Risk: Baseline Characteristics of the Impact of Phosphate Reduction On Vascular End-Points in Chronic Kidney Disease Trial', American Journal of Nephrology, 51, pp. 201 - 215, http://dx.doi.org/10.1159/000505717

Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K, 2020, 'Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry', Peritoneal Dialysis International, 40, pp. 209 - 219, http://dx.doi.org/10.1177/0896860819894058

Walsh M; Merkel PA; Peh C-A; Szpirt WM; Puéchal X; Fujimoto S; Hawley CM; Khalidi N; Floßmann O; Wald R; Girard LP; Levin A; Gregorini G; Harper L; Clark WF; Pagnoux C; Specks U; Smyth L; Tesar V; Ito-Ihara T; de Zoysa JR; Szczeklik W; Flores-Suárez LF; Carette S; Guillevin L; Pusey CD; Casian AL; Brezina B; Mazzetti A; McAlear CA; Broadhurst E; Reidlinger D; Mehta S; Ives N; Jayne DRW; Badve S, 2020, 'Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis', New England Journal of Medicine, 382, pp. 622 - 631, http://dx.doi.org/10.1056/nejmoa1803537

Chou A; Long C; Vonthethoff L; Ho SJ; Pettit F; Badve SV, 2020, 'Crystalglobulinemia in Multiple Myeloma: A Rare Case Report of Survival and Renal Recovery', Canadian Journal of Kidney Health and Disease, 7, http://dx.doi.org/10.1177/2054358120922629

Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; Chen JHC; Sypek M; Johnson DW, 2020, 'Multicentre registry data analysis comparing outcomes of culture-negative peritonitis and different subtypes of culture-positive peritonitis in peritoneal dialysis patients', Peritoneal Dialysis International, 40, pp. 47 - 56, http://dx.doi.org/10.1177/0896860819879891

Hockham C; Bao L; Tiku A; Badve S; Gallagher MP; Jardine MJ; Jha V; Woodward M; Jun M, 2020, 'Sex Differences in CKD Prevalence in Asia: A Systematic Review and Meta-Analysis', Journal of the American Society of Nephrology, 31, pp. 179 - 179, http://dx.doi.org/10.1681/asn.20203110s1179c

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'The Effects of Allopurinol on the Progression of CKD According to Baseline Kidney Function: Prespecified Analyses of the CKD-FIX Trial', Journal of the American Society of Nephrology, 31, pp. 228 - 229, http://dx.doi.org/10.1681/asn.20203110s1228d

Tiku A; Pascoe E; Boudville N; Cass A; Dalbeth N; Day RO; de Zoysa J; Douglas B; Faull R; Harris D; Hawley C; Jones GR; Kanellis J; Palmer S; Perkovic V; Rangan G; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW; Badve S, 2020, 'The Effects of Allopurinol on the Progression of CKD According to Baseline Serum Urate Level: Results from Post Hoc Analyses of the CKD-FIX Trial', Journal of the American Society of Nephrology, 31, pp. 223 - 223, http://dx.doi.org/10.1681/asn.20203110s1223a

Li JW; Badve SV; Zhou Z; Rodgers A; Day R; Oh R; Lee M; Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Matthews DR; Neal B, 2019, 'The effects of canagliflozin on gout in type 2 diabetes: a post-hoc analysis of the CANVAS Program', The Lancet Rheumatology, 1, pp. e220 - e228, http://dx.doi.org/10.1016/S2665-9913(19)30078-5

Ha JT; Neuen BL; Cheng LP; Jun M; Toyama T; Gallagher MP; Jardine MJ; Sood MM; Garg AX; Palmer SC; Mark PB; Wheeler DC; Jha V; Freedman B; Johnson DW; Perkovic V; Badve SV, 2019, 'Benefits and harms of oral anticoagulant therapy in chronic kidney disease', Annals of Internal Medicine, 171, pp. 181 - 189, http://dx.doi.org/10.7326/M19-0087

LI J; BADVE SV; ZHOU Z; OH R; LEE M; PERKOVIC V; ZEEUW DD; MAHAFFEY KW; FULCHER G; MATTHEWS DR; NEAL B, 2019, '1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p

Boudville N; Ullah S; Clayton P; Sud K; Borlace M; Badve SV; Chakera A; Johnson DW, 2019, 'Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies', Nephrology Dialysis Transplantation, 34, pp. 1035 - 1044, http://dx.doi.org/10.1093/ndt/gfy340

Yeung WCG; Toussaint ND; Badve SV, 2019, 'Dual inhibition of gastrointestinal phosphate absorption: More questions than answers', Journal of the American Society of Nephrology, 30, pp. 909 - 910, http://dx.doi.org/10.1681/ASN.2019040333

Ha JT; Badve SV; Jun M, 2019, 'Recent evidence for direct oral anticoagulants in chronic kidney disease', Current Opinion in Nephrology and Hypertension, 28, pp. 251 - 261, http://dx.doi.org/10.1097/MNH.0000000000000493

Viecelli AK; Polkinghorne KR; Pascoe EM; Paul-Brent PA; Hawley CM; Badve SV; Cass A; Hooi LS; Kerr PG; Mori TA; Ong LM; Voss D; Johnson DW; Irish AB, 2019, 'Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial', PLoS ONE, 14, http://dx.doi.org/10.1371/journal.pone.0213274

Lioufas N; Toussaint ND; Pedagogos E; Elder G; Badve SV; Pascoe E; Valks A; Hawley C; Block GA; Boudville NC; Campbell K; Cameron JD; Chen SSM; Faull RJ; Holt SG; Hooi LS; Jackson D; Jardine MJ; Johnson DW; Kerr PG; Lau KK; Morrish A; Perkovic V; Polkinghorne KR; Pollock CA; Reidlinger D; Robison L; Smith ER; Walker RJ; Wang AYM; Badve S, 2019, 'Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study', BMJ Open, 9, pp. e024382, http://dx.doi.org/10.1136/bmjopen-2018-024382

Conley M; Toussaint ND; Pedagogos E; Lioufas N; Elder GJ; Badve SV; Hawley CM; Pascoe EM; Valks A; Campbell KL, 2019, 'SAT-224 ESTIMATES OF DIETARY PHOSPHATE CONSUMPTION AND COMMON FOOD SOURCES OF PHOSPHATE IN AUSTRALIANS WITH CHRONIC KIDNEY DISEASE', Kidney International Reports, 4, pp. S100 - S100, http://dx.doi.org/10.1016/j.ekir.2019.05.259

YEUNG WCG; Talbot B; Shah N; Palmer S; Mangos G; Gallagher M; Toussaint N; Badve S, 2019, 'SUN-292 BENEFITS AND HARMS OF VITAMIN D COMPOUNDS IN ADULTS WITH CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', Kidney International Reports, 4, pp. S281 - S281, http://dx.doi.org/10.1016/j.ekir.2019.05.797

Tiku A; Badve SV; Johnson DW, 2018, 'Urate-Lowering Therapy for Preventing Kidney Disease Progression: Are We There Yet?', American Journal of Kidney Diseases, 72, pp. 776 - 778, http://dx.doi.org/10.1053/j.ajkd.2018.07.022

Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GFM; Cho Y, 2018, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD007554.pub3

Lo C; Toyama T; Wang Y; Lin J; Hirakawa Y; Jun M; Cass A; Hawley CM; Pilmore H; Badve SV; Perkovic V; Zoungas S, 2018, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews, 2018, http://dx.doi.org/10.1002/14651858.CD011798.pub2

See EJ; Johnson DW; Hawley CM; Pascoe EM; Badve SV; Boudville N; Clayton PA; Sud K; Polkinghorne KR; Borlace M; Cho Y, 2018, 'Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study', American Journal of Kidney Diseases, 72, pp. 188 - 197, http://dx.doi.org/10.1053/j.ajkd.2017.10.019

Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2018, 'Outcomes of acinetobacter peritonitis in peritoneal dialysis patients: A multicenter registry analysis', Peritoneal Dialysis International, 38, pp. 257 - 265, http://dx.doi.org/10.3747/pdi.2017.00199

Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2018, 'Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry', American Journal of Kidney Diseases, 71, pp. 814 - 821, http://dx.doi.org/10.1053/j.ajkd.2017.10.017

See E; Johnson D; Hawley C; Pascoe E; Badve S; Boudville N; Clayton P; Sud K; Polkinghorne K; Borlace M; Cho Y, 2018, 'FP468RISK PREDICTORS AND CAUSES OF TECHNIQUE FAILURE WITHIN THE FIRST YEAR OF PERITONEAL DIALYSIS', Nephrology Dialysis Transplantation, 33, pp. i194 - i194, http://dx.doi.org/10.1093/ndt/gfy104.fp468

Jegatheesan D; Johnson DW; Cho Y; Pascoe EM; Darssan D; Htay H; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Nadeau-Fredette AC, 2018, 'The relationship between body mass index and organism-specific peritonitis', Peritoneal Dialysis International, 38, pp. 206 - 214, http://dx.doi.org/10.3747/pdi.2017.00188

Wong ATY; Mannix C; Grantham JJ; Allman-Farinelli M; Badve SV; Boudville N; Byth K; Chan J; Coulshed S; Edwards ME; Erickson BJ; Fernando M; Foster S; Haloob I; Harris DCH; Hawley CM; Hill J; Howard K; Howell M; Jiang SH; Johnson DW; Kline TL; Kumar K; Lee VW; Lonergan M; Mai J; McCloud P; Peduto A; Rangan A; Roger SD; Sud K; Torres V; Vliayuri E; Rangan GK, 2018, 'Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)', BMJ Open, 8, pp. e018794, http://dx.doi.org/10.1136/bmjopen-2017-018794

Htay H; Cho Y; Pascoe EM; Darssan D; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW, 2017, 'Outcomes of corynebacterium peritonitis: A multicenter registry analysis', Peritoneal Dialysis International, 37, pp. 619 - 626, http://dx.doi.org/10.3747/pdi.2017.00028

Viecelli AK; Pascoe EM; Polkinghorne KR; Hawley CM; Paul-Brent PA; Badve SV; Cass A; Johnson DW; Kerr PG; Mori TA; Scaria A; Hooi LS; Ong LM; Irish AB, 2017, 'Updates on baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study', Nephrology, 22, pp. 823 - 824, http://dx.doi.org/10.1111/nep.12823

Back to profile page